APA (7th ed.) Citation

N, A., LS, A., SA, S., A, C., J, V., N, V., . . . U, Ş. (2026). mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models. Nature immunology, 27(8), 1653. https://doi.org/10.1038/s41590-026-02545-z

Chicago Style (17th ed.) Citation

N, Agrawal, et al. "MRNA-based Tuberculosis Vaccines BNT164a1 and BNT164b1 Are Immunogenic, Well Tolerated and Efficacious in Rodent Models." Nature Immunology 27, no. 8 (2026): 1653. https://doi.org/10.1038/s41590-026-02545-z.

MLA (9th ed.) Citation

N, Agrawal, et al. "MRNA-based Tuberculosis Vaccines BNT164a1 and BNT164b1 Are Immunogenic, Well Tolerated and Efficacious in Rodent Models." Nature Immunology, vol. 27, no. 8, 2026, p. 1653, https://doi.org/10.1038/s41590-026-02545-z.